Anna Wójcicka

8PUBLICATIONS
17CO-AUTHORS
Molecular targetsBiologically active moleculesInfectious agentsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 27, 2026
A Novel 2,7-Naphthyridine Derivative Suppresses Ovarian Cancer Cell Growth Through G1 Cell Cycle Arrest, Apoptosis Induction and Migration Inhibition.

|Mar 28, 2026
Anti-Inflammatory Activity of Cyclic Imide Derivatives.

Aleksandra Redzicka, Beata Tylińska, Anna Wójcicka

|Nov 13, 2025
Evaluation of 2,7-Naphthyridines as Targeted Anti-Staphylococcal Candidates with Microbiota-Sparing Properties.

Anna Wójcicka, Maciej Spiegel, Bartłomiej Dudek

|Mar 11, 2025
7-(4-Chlorophenyl)-1-hydroxy-5-methylpyrido[3,4-d]pyridazin-4(3H)-one: synthesis, solvatomorphism, in vitro anti-inflammatory and cytotoxic activity studies and in silico analysis.

Anna Wójcicka, Iwona Bryndal, Magdalena Krupińska

|Jan 08, 2025
Antimicrobial Activity of Naphthyridine Derivatives.

Anna Wójcicka, Marcin Mączyński

|Oct 05, 2022
Structure and cytotoxic properties of 1-hydroxy-5-methyl-7-phenylpyrido[3,4-d]pyridazin-4(3H)-one and its mono- and disubstituted ethyl acetates.

Anna Wójcicka, Lilianna Becan, Nina Rembiałkowska

Pageof 2

Frequent Collaborators

3 joint publications

Marcin Mączyński

2 joint publications

Aleksandra Redzicka

1 joint publications

Gabriela Chabowska

1 joint publications

Ewa Barg